Yüklüyor......
Treatment of Non-Small-Cell Lung Cancer with Erlotinib following Gefitinib-Induced Hepatotoxicity: Review of 8 Clinical Cases
Objective. Gefitinib often induces liver damage. A few reports have described that the subsequent administration of erlotinib was associated with less hepatotoxicity, but the safety and efficacy of this treatment are still not fully investigated. Therefore, we evaluated retrospectively the patients...
Kaydedildi:
| Yayımlandı: | Lung Cancer Int |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Hindawi Publishing Corporation
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4437396/ https://ncbi.nlm.nih.gov/pubmed/26316933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/354657 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|